olmesartan has been researched along with pyrilamine in 1 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (pyrilamine) | Trials (pyrilamine) | Recent Studies (post-2010) (pyrilamine) |
---|---|---|---|---|---|
841 | 185 | 554 | 1,860 | 26 | 116 |
Protein | Taxonomy | olmesartan (IC50) | pyrilamine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.13 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.976 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.3 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.997 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.13 | |
Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 0.0015 | |
Histamine H1 receptor | Rattus norvegicus (Norway rat) | 0.0126 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.047 | |
Histamine H1 receptor | Homo sapiens (human) | 0.0166 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 2.788 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.879 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.1 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.558 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
1 other study(ies) available for olmesartan and pyrilamine
Article | Year |
---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |